Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1075 of 6351
-
Breath test and antibiotics aim to slash stomach cancer in indigenous communities
Prevention Recruiting nowThe incidence of gastric cancer in local indigenous peoples is higher than the non-Indigenous counterpart in Taiwan. How to design an effective prevention strategy for gastric cancer is of importance. The present study aimed to identify the causes that may account for the health …
Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
Spiral seed strand boosts survival and cuts complications in bile duct cancer jaundice
Disease control CompletedThis study aimed to compare the safety and effectiveness of two different methods for fabricating and implanting Iodine-125 (\^125\^I) radioactive seed strands combined with a metal stent for treating malignant obstructive jaundice. The conventional method uses a straight seed st…
Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Freezing heart rhythms: could a cold balloon tame AFib in failing hearts?
Disease control CompletedThe combination of atrial fibrillation (AF) and heart failure (HF) is common and implies a poor prognosis. Pulmonary vein isolation is an established method for the treatment of symptomatic AF in patients with normal heart function and has been shown to be more effective than dru…
Sponsor: St. Josefs-Hospital Wiesbaden GmbH • Aim: Disease control
Last updated Jun 26, 2026 16:16 UTC
-
New heart ablation tech under scrutiny: can it tame dangerous rhythms?
Disease control Recruiting nowThe primary purpose of this Registry is to assess procedural safety and long-term effectiveness of catheter ablations in the treatment of subjects with PAF, PsAF, and VA. The Registry will utilize real world clinical data obtained from the use of commercially available CARTO™ tec…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a higher steroid dose help preterm babies breathe easier?
Disease control CompletedThe goal of this observational study was to compare two doses of dexamethasone given to pregnant women at risk of preterm birth. Dexamethasone is a medicine used before birth to help a baby's lungs mature. This study looked at preterm babies born between 26 and 36 weeks of pregn…
Sponsor: Stella Maris Women and Children Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Clot removal vs. meds: which works better for mild stroke?
Disease control CompletedThe purpose of TRIMIS is to study how a medical procedure by the name of endovascular therapy compares to medical treatment alone in patients with mild stroke and a blood vessel occlusion in the brain
Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New device aims to plug leaky heart valve in heart failure patients
Disease control Recruiting nowThe objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
Sponsor: Cardiac Dimensions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can adding surgery or radiation to immunotherapy boost survival in advanced lung cancer?
Disease control OngoingThis phase III trial studies how well nivolumab and ipilimumab works with or without local consolidation therapy in treating patients with stage IV non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune s…
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New immune cell combo targets hard-to-treat breast cancer
Disease control OngoingThis proposal uses HER2Bi armed activated T-cells (HER2 BATs) to target breast cancer in combination with pembrolizumab (PBZ) in women with metastatic breast cancer (MBC). Phase I will determine a safe dose of the combination of PBZ and HER2 BATs in 3 to 18 patients. In the phase…
Phase 1/2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Immunotherapy duo takes on rare cancers
Disease control OngoingThis research study is studying a combination of drugs as a possible treatment for rare genitourinary malignancies among four cohorts, bladder or upper tract carcinoma with variant histology, adrenocortical carcinoma, other rare genitourinary carcinomas and any genitourinary carc…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a common malaria drug stop lupus before it starts?
Prevention CompletedThis project is a multicenter, randomized, placebo-controlled, double-blind clinical trial that is designed to test whether treating patients who are at risk for development of lupus with hydroxychloroquine can slow accumulation of disease features. Effects on clinical progressio…
Phase 2 • Sponsor: Milton S. Hershey Medical Center • Aim: Prevention
Last updated Jun 26, 2026 18:33 UTC
-
New combo therapy shows promise for hard-to-treat thyroid cancer
Disease control CompletedThis is a multicentric prospective non-randomized phase II trial, with two independent arms: one for patients with RAS mutation and one for patients with BRAFV600E mutation.
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New immunotherapy cocktails aim to tackle Hard-to-Treat breast cancer
Disease control CompletedThis study is designed to evaluate the efficacy, safety, and pharmacokinetics of several immunotherapy-based combination treatments in participants with inoperable locally advanced or metastatic HR-positive, HER2-negative breast cancer who have progressed during or following trea…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a tendon sling end repeat shoulder dislocations?
Disease control OngoingThe arthroscopic subscapular sling procedure is a new technique for shoulder stabilization, which has been developed in human cadaveric studies by Klungsøyr et al, but has yet to be tested clinically. The procedure stabilizes the shoulder by using a semitendinosus graft that make…
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Double-Drug attack shows promise for tough head and neck cancers
Disease control CompletedThe purpose of this study is to find out if the combination of two established anti-cancer therapies are beneficial in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Specifically, investigators want to determine if the combination of Cetuximab and nivolumab can …
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy shows promise for tough prostate cancer
Disease control CompletedThe purpose of this study is to assess safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate cancer that has spread.
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedA multicenter, phase 3, long-term extension trial of TransCon hGH administered once-weekly in children with growth hormone deficiency (GHD) who previously participated in a phase 3 TransCon hGH trial. Approximately 300 children (males and females) with GHD will be included. All s…
Phase 3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for lung cancer patients who failed immunotherapy: targeted drug combo trial launches
Disease control OngoingThis is an open-label, multi-centre, umbrella Phase II study in participants with metastatic NSCLC who have progressed on an anti-PD-1/PD-L1 containing therapy. This study is modular in design, allowing initial assessment of the efficacy, safety, and tolerability of multiple trea…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug talquetamab targets Hard-to-Treat myeloma in first human trial
Disease control OngoingThe purpose of this study is to characterize the safety of Talquetamab and to determine the recommended Phase 2 dose(s) (RP2Ds) and dosing schedule assessed to be safe for Talquetamab (Part 1 \[Dose Escalation\]) and to further characterize the safety of Talquetamab at the recomm…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Leg-saving vein bypass shows promise for worst-case artery disease
Disease control CompletedThe objective of this post-market study is to evaluate the safety and effectiveness of the LimFlow System in creating a below-the-knee arterio-venous fistula for venous arterialization in subjects with critical limb ischemia.
Sponsor: LimFlow SA • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC